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ABSTRACT 
Burn-induced insulin resistance is associated with increased morbidity and mortality; 
however, the impact of burn injury on tissue-specific insulin sensitivity and its 
molecular mechanisms with consideration of insulin state remains unknown in rodent 
models. This study was designed to characterize a burn mouse model with 
tissue-specific insulin resistance under insulin clamp conditions. C57BL6/J mice were 
subjected to 30% full-thickness burn injury and underwent the combination of 
hyperinsulinemic isoglycemicclamp (HIC) and positron emission tomography (PET). 
Hepatic glucose production (HGP) and peripheral glucose disappearance rate (Rd) were 
measured at different time points up to 7 days post injury. Burned mice showed a 
significant fasting hypoglycemia and hypoinsulinemia (P < 0.01) on post-burn day 
(PBD) 3 and 7 along with significantly higher energy expenditure (P < 0.01). HICon 
PBD 3 demonstrated that burn injury induced systemic insulin resistance, resulting from 
a significant decrease in insulin-stimulated Rd (33.0 ± 10.2 vs 68.3 ± 5.9 mg/kg/min; P 
< 0.05). In contrast, HGP of burned and sham mice was comparable both in the basal 
and clamp period. PET on PBD 3 showed a lower insulin-stimulated 18F-labeled 
2-fluoro-2-deoxy-D-glucose uptake in the quadriceps of burned mice compared with
sham-burned mice. Gastrocnemius muscle harvested from burned mice on PBD 3 
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showed decreased insulin-stimulated tyrosine phosphorylation of insulin receptor 
substrate-1 to 34.7% of that in sham-burn mice by immunoblotting analysis (P < 0.05). 
These findings suggest that impaired insulin-stimulated Rd in skeletal muscle, not 
elevated HGP, plays a role in the development of burn-induced insulin resistance in a 
mouse model.  
Key words: insulin resistance; burn injury; insulin clamp; positron emission 
tomography; hypermetabolism 
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INTRODUCTION 
 Critically ill patients including those with burn injury develop insulin resistance and 
hyperglycemia, which lead to poor wound healing(30), skeletal muscle wasting (26), 
and increased mortality(10, 25).  Intensive insulin therapy has been shown to improve 
glucose homeostasis in burned children(9); however, the increased incidence of 
hypoglycemic episodes with negative outcomes(1, 4, 17) requires a better understanding 
of the underlying molecular mechanism(s) of the burn-induced insulin resistance.  This 
new knowledge will  likely contribute to improved patient outcomes and more targeted 
approaches to therapy. 
 It is well recognized that acute insulin resistance is complex and tissue specific in 
liver, skeletal muscle, and adipose tissue(19-21). Studies investigating the potential 
molecular mechanisms for burn induced insulin resistance have demonstrated that burn 
injury impairs the insulin receptor substrate (IRS)-1/ phosphatidyl- inositol 3-kinase 
(PI3K)/ Akt signal pathway in liver(3) and skeletal muscle(13, 14, 28).  These 
findings, however, were obtained from isolated tissues from rodent burn models after 
differing doses of insulin challenge and only whole-body glucose metabolism was 
assessed, by glucose tolerance test (GTT) and/or insulin tolerance test (ITT).  We 
believe that the investigations exploring molecular mechanism(s) should be conducted 
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on appropriate tissue sample which reflects an accurate tissue-specific insulin resistance 
in vivo evaluated by well-characterized animal models. Recently, we reported that burn 
injury was associated with a 49% increase in hepatic glucose production (HGP) in the 
fasting state with post-burn hyperglycemia by the hyperinsulinemic-euglycemic clamp  
technique in a rabbit model(31). The insulin clamp technique is the gold standard for 
quantitative assessment of insulin sensitivity(6). Ininsulin clamp technique, whole-body 
insulin action is qualified as the glucose infusion rate (GIR) required to maintain 
euglycemia or isoglycemia in response to a constant rate of insulin infusion.  
Additionally, HGP and the rate of peripheral glucose disappearance (Rd) can be 
obtained by infusing radioisotope glucose.  Furthermore, positron emission 
tomography (PET), a quantitative imaging technique, allows the assessment of glucose 
dynamics in individual tissues of living animals.  The combination of insulin clamp 
and PET techniques allows for the evaluation of glucose metabolism in individual 
tissues. Although these approaches are technically challenging to perform in small 
animals, a well-characterized burn mouse model has been utilized in the development of 
genetically modified animals, with tissue-specific knockout of the insulin receptor(2, 
16). The purpose of the current study was to characterize both the impact of burn injury 
on tissue-specific insulin sensitivity and the molecular basis of insulin resistance under 
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insulin clamp conditions in a mouse model utilizing the combination of the insulin 
clamp technique and PET. 
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MATERIALS AND METHODS 
 Animals. All procedures were approved by the Institutional Animal Care Committee 
(IACUC) at Massachusetts General Hospital. The animal care facility is accredited by 
the Association for Assessment and Accreditation of Laboratory Animal Care 
(AAALAC). Male 10 to 12-week-old C57BL/6 mice (Charles River Laboratories; 
Wilmington, MA) were housed in a pathogen-free animal facility at Shriners Hospital 
under controlled temperature, humidity, and a 12:12h light-dark cycle. The mice were 
provided with standard rodent chow and water ad libitum. A full-thickness third-degree 
burn injury comprising 30% of total body surface area was produced by immerging the 
abdomen for 6 sec and both flanks for 4 sec in 80◦C water under general anesthesia with 
ketamine (100 mg/kg BW, IP) and xylazine (10 mg/kg BW, IP). We confirmed that this 
procedure produced full-thickness burn injury by light microscopy of hematoxylin and 
eosin stained sections. Sham-burn animals were treated in the same manner with the 
exception that these animals were immerged in room temperature water.  Immediately 
after burn or sham-burn, all animals received fluid resuscitation with normal saline (40 
ml/kg BW, IP). Buprenorphine (0.1 mg/kg BW, IM) was administered every 12 h for up 
to 72 h after the injury. This study was conducted in pair-fed burn and sham-burned 
mice. 
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 Indirect calorimetric analysis. At 1, 3 and 7 days after burn or sham-burn, indirect 
gas calorimetry (TSE Systems, Germany) was used to evaluate respiratory exchange 
ratio (RER), energy expenditure (EE), oxygen consumption (VO2), and resting carbon 
dioxide production (VCO2). These parameters were calculated automatically by a 
computer system based on body weight. The mice were placed into a temperature- and 
humidity-controlled metabolic chamber for 24 h and had ad libitum access to water and 
food. 
Glucose tolerance test (GTT). At 1, 3, 7 days after burn or sham-burn and following 
15-h of fasting, 2.0 g/kg of glucose was injected intraperitoneally. Blood glucose levels
and plasma insulin concentration were measured by sampling blood from the tail vein 
using a FreeStyle Lite glucometer (Abbott, Almeda, CA) and ELISA kit (CRYSTAL 
CHEM INC, Downers Grove, IN) before and at 15, 30, 60, 90, 120 min after glucose 
injection.  
 Insulin tolerance test (ITT). At 1, 3, 7 days after burn or sham-burn, following 5-h 
of fasting, mice were injected into the abdomen with insulin (1.0 U/kg BW; Humulin R, 
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Eli Lilly, dianapolis, IN). Blood glucose levels obtained from the tail vein were recorded 
for 120 min after the insulin injection.  
 Hyperinsulinemic-sisoglycemic clamp (HIC) in a conscious mouse. We performed 
the HIC technique, which maintained blood glucose at fasting levels, because basal 
blood glucose level differed significantly between burn and sham-burn mice in 
preliminary experiments and large acute changes in glycemia may alter insulin 
sensitivity(22).  Four days before burn or sham-burn, the mice were anesthetized with 
2.0% of isoflurane and a polyurethane catheter (0.025” outer diameter) was inserted into 
the right jugular vein for infusions. Animals were housed individually after the surgery, 
and their body weight (BW) and food consumption  were recorded daily.  
 At 1, 3, 7 days after burn or sham-burn, following 13-h fasting, the mice were 
placed into a rat-sized restrainer (2.5” diameter and 8.5” long) with tail-tethered for 
blood sampling. After 2-h acclimatization, baseline blood glucose and plasma insulin 
concentrations were determined.  The protocol consisted of a 90-min tracer 
equilibration period (t = -90 min to 0 min) and a 120-min clamp period (t = 0 min to 120 
min). A 600 μmol/kg bolus injection of [U-13C6] glucose (Cambridge Isotope 
Laboratories, Andover, MA) was administered at t = -90 min, followed by a 7.5 μmol/ 
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kg/min infusion for 90 min. The HIC was initiated at t = 0 min with a bolus insulin 
injection (50 mU/kg BW) for 3 min followed by continuous insulin infusion (2.5 mU/kg 
BW) for 120 min. Blood glucose concentration was determined every 10 min to adjust 
the infusion rate of 50% dextrose (Hospira, Lake Forest, IL) to maintain the target 
glucose level at baseline concentration ± 10 mg/dl. Steady state of the clamp was 
defined as a 30-min or longer period during which the coefficient of variation for GIR 
and blood glucose were less than 5%. Blood samples (40 - 60 μl) were taken every 15 
min from t = 75 min to determine [U-13C6] glucose enrichment. The clamp plasma 
insulin concentrations were determined from the sample taken at t = 120 min. The 
enrichments of [U-13C6] glucose were measured by gas chromatography mass 
spectrometry (GC-MS, Hewlett Packard 5985B GC/MS System, Palo Alto, CA) as 
described previously(31). Immediatly after HIC, the mice were anesthetized with 
sodium pentobarbital (100 mg/kg BW, IP), and gastrocnemius muscle was excised. The 
tissue samples were snap-frozen and kept –80◦ C until the biochemical analysis. 
 
 Calculations.  Whole body glucose turn over (Ra) was determined with the 
steady-state isotope tracer dilution approach as described previously (26): Ra = Qiso 
(Eiso/ Ep – 1), where Qiso is the infusion rate of [U-13C6] glucose, Eiso is the isotope 
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enrichment of [U-13C6] glucose in the infusate, and Ep is the plateau level of [U-13C6] 
glucose enrichment. HGP was calculated by subtracting the GIR from Ra. The glucose 
clamp-derived index of insulin sensitivity (SIclamp) was defined as M/(G x ΔI), where M 
is the steady state of GIR, G is the steady state blood glucose concentration, and ΔI is 
the difference between basal and steady state plasma insulin concentrations(15). 
Spearman rank-coefficient of correlation value between GIR at steady state and SIclamp 
was measured.   
 
 MicroPET.  We prepared a separate group of mice in the same manner as the HIC 
animals for microPET study. At 3 days after burn or sham-burn injury, microPET was 
conducted at fasting (basal) and steady state condition (clamp) to investigate individual 
muscle glucose metabolism at different conditions. Following 30-min steady state with 
HIC (clamp), or without HIC (basal), the mice were transferred to the gantry of a 
microPET Focus 220 camera (Siemens Medical Solutions, Knoxville, TN) and 
anesthetized with 1.0% isoflurane. Blood glucose concentration was controlled at 
fasting level throughout the study. 1.2mCi of 18F-labeled 2-fluoro-2-deoxy-D-glucose 
(18FDG) obtained from PETNET Solutions (Woburn, MA) was injected intravenously 
through the catheter with immediate start of dynamic PET image acquisition.  The 
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dynamic acquisition with 1 min frames was performed for 25 min followed by 5 min 
static acquisition recorded at 30 min post administration. Imaging was carried out using 
a custom PET/CT imaging system consisting of MicroPET Focus 220 PET scanner 
(Siemens Medical Solutions, TN) and CereTom NL 3000 CT scanner (Neurologica, 
MA, USA).  
 Five circular regions of interest were manually drawn inside selected tissue, and the 
mean activity concentration was corrected for radioactive decay, and expressed as 
standardized uptake value (SUV).  
 
 Tissue homogenization and immunoblotting. Gastrocnemius muscle excised from 
the 15h-fasted mice (basal) or mice that underwent HEC (clamp) were homogenized 
using a electric homogenizer (Cole-Parmer, Vernon Hills, IL) in ice-cold 
homogenization buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM 
Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM 
beta-glycerophosphate, 1 mM Na3VO4, 1 µg/ml leupeptin (Cell Signaling, Danvers, 
MA) and 1 mM Phenylmethanesulfonyl fluoride (Sigma, St. Louis, MO), followed by 
centrifuging at 14,000 g for 10 min at 4oC. Equal amounts of protein were subjected to 
SDS-polyacrylamide gel electrophoresis and were transferred to 0.2-µm nitrocellulose 
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membranes (BioRad, Herculs, CA). The membranes were blocked with Odyssey 
blocking buffer (Odyssey, Lincoln, NE) for 1h at room temperature, followed by 
incubation overnight at 4oC with anti-glyceraldehyde 3- phosphate dehydrogenase 
(GAPDH) (#2118),anti-Akt (#4691), anti-phospho-Akt at serine 473 (#4060), 
anti-IRS-1 (#2390) (Cell Signaling, Danvers, MA), and anti-phospho IRS-1 at tyrosine 
612 (#44-816G) (Life Technologies, Grand Island, NY). The membranes were then 
incubated with goat anti-rabbit IRDye 800 (LI-COR, Lincoln, NE) for 1h at room 
temperature, and were scanned with an Odyssey Infrared Imaging System (LI-COR, 
Lincoln, NE). The images were analyzed using the Odyssey Application Software, 
version 4.0 (LIL-COR, Lincoln, NE) to obtain integrated intensities. The obtained 
intensities were normarized by GAPDH. 
 
 Statistical analysis. Statistical analysis was performed using GraphPad Prism 
software (GraphPad Software, San Diego, CA). The data were compared with unpaired 
t-test unless otherwise noted and repeated measure based parameters (such as BW, and 
GIR) were analyzed using two-way ANOVA followed by the Bonferroni post hoc 
multiple comparisons test. A value of P < 0.05 was considered statistically significant.  
All results were expressed as mean ± SE. 
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RESULTS 
Hypermetabolism, catabolism, and unexpected hypoglycemia 
 Animals with 30% TBSA burn injury demonstrated a significant decrease in BW on 
and after PBD 3 compared with sham-burned animals (Fig. 1A). The weight of 
gastrocnemius muscle and epididymal adipose tissue in burned mice was significantly 
decreased on PBD 7 (Gastrocnemius; 0.6 ± 0.02 vs 0.4 ± 0.03% BW, P < 0.05, 
Epididymal; 1.6 ± 0.2 vs 0.9 ± 0.1% BW, P < 0.01) (Fig. 1B). In contrast, the liver 
weight of burned mice was significantly increased on PBD 7 (6.0 ± 0.3 vs 5.0 ± 0.1% 
BW, P < 0.05) (Fig. 1B). The indirect calorimetry study demonstrated that burn injury 
significantly increased EE on PBD 3 (19.3 ± 2.3 vs 14.1 ± 2.3 kcal/kg•h, P < 0.01) and 
7 (18.1 ± 2.4 vs 13.3 ± 1.8 kcal/kg•h, P < 0.01), along with increased VO2, and VCO2 
(Fig. 1C-G). These findings indicate that our animal model of burn injury is consistent 
with the clinical course of burn patients with respect to hypermetabolism and 
catabolism.  Blood sampling after 15-h fasting, however, demonstrated significant 
hypoglycemia and hypoinsulinemia in the burned mice on PBD 3 and 7, which resulted 
in significantly lower Homeostasis Model Assessment of Insulin Resistance 
(HOMA-IR, estimate of steady state beta cell function and insulin sensitivity as 
percentages of a normal reference population) in burned mice on PBD 3 and 7 compared 
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with sham-burn mice (Table 1). 
 
Systemic insulin resistance on post burn day 3 by indirect measurements  
 We performed indirect measurements including GTT and ITT at various time points 
to assess the impact of burn injury on systemic glucose tolerance and insulin sensitivity 
in this animal model.  Areas under the curve (AUCs) of blood glucose (Fig. 2A-C) and 
plasma insulin concentration (Fig. 2D-F) after GTT, calculated by the trapezoidal 
formula, were comparable between burn and sham-burn mice throughout the study 
period.  In contrast, ITT (Fig. 2G-I) showed a significantly higher AUC of blood 
glucose on PBD 3 compared with sham-burn mice (8569 ± 353 vs 6625 ± 213 mg/dL, P 
< 0.01) (Fig. 2H). These findings suggested that this animal model induced whole-body 
insulin resistance on PBD 3 although the animals did not develop glucose intolerance.  
 
Decreased insulin-stimulated glucose utilization in perioheral tissues by 
hyperinsulinemic isoglycemic clamp 
 We conducted HICat various time points to validate the ITT results and determine  
whether HGP and/or peripheral Rd contributed to burn-induced insulin resistance.  
Blood glucose level during the clamp period was maintained at the target range both in 
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burn and sham-burn mice at each time point (Fig. 3A-C). However, burned mice on 
PBD 3 showed a significantly lower GIR than that of sham-burn mice (AUC GIR: 3383 
± 604 vs 7450 ± 503 mg/kg/min, P < 0.01) (Fig. 3E), which indicates that burn injury 
induces systemic insulin resistance on PBD 3.  There were no significant differences in 
AUCs of GIR between burn and sham-burn mice on PBD 1 and 7 (Fig. 3D and F).  
These results were in agreement with the results using SIclamp, which is recognized as a 
more appropriate method than GIR for the isoglycemic clamp technique because it 
normalizes for differences in fasting glucose levels (22). SIclamp of burned mice on PBD 
3 was also significantly lower than that of sham-burn mice (0.58 ± 0.23 vs 1.16 ± 0.14, 
P < 0.05), and SIclamp showed a significant positive correlation with GIR at steady state 
(r2 = 0.56, P < 0.01) (Fig. 3G). 
 HGP and peripheral Rd were determined by gas chromatography mass spectrometry.  
HGP on PBD 3 showed no significant difference during the basal and clamp period 
(Fig. 3H). In contrast, insulin stimulated-Rd of burned mice on PBD 3 was significantly 
lower than in sham-burn mice (33.0 ± 10.2 vs 68.3 ± 5.9 mg/kg/min, P < 0.05) (Fig. 3I).  
Additionally, plasma insulin concentration during the clamp period was maintained at a 
comparable level between burned and sham-burned animals at each time point (Fig. 3J). 
The results showed that impaired insulin-stimulated Rd in peripheral tissue acompanied 
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with unelevatedHGP plays an important role in developing the insulin resistance of 
burned mice under insulin clamp conditions.  
Decreased insulin-stimulated glucose utilization in skeletal muscle by hyperinsulinemic 
isoglycemic clamp and microPET  
 We conducted microPET following HIC on PBD 3 to further investigate the glucose 
dynamics in the individual tissues.  MicroPET in the basal period showed that 18FDG 
uptake in the quadriceps was comparable between burn and sham-burn mice; however, 
during the clamp period, insulin infusion promoted 18FDG uptake in the quadriceps of 
sham-burned mice more than in burned mice (Fig. 4A). Quantitative analysis of SUV 
showed that insulin-stimulated SUV in the right quadriceps of burned mice was 
significantly lower than that in sham-burn mice (Fig. 4B). These results are further 
supported in the data to follow showing that burn injury impairs insulin-stimulated 
glucose disappearance in the skeletal muscle, and this impairment plays a key role in the 
development of burn-induced insulin resistance under insulin clamp condition.  
Inhibition of IRS-1/ Akt mediated insulin signaling in skeletal muscle 
We conducted western blot analysis using the gastrocnemius muscles at various time 
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points after injury to investigate alterations in insulin signaling in skeletal muscle under 
insulin clamp conditions.  Representative images of blot were shown as Fig.5A. 
Although IRS-1 expression was not altered by burn injury (Fig. 5B), insulin- stimulated 
tyrosine phosphorylation of IRS-1 in burned mice on PBD 3 was decreased to 34.7% of 
that in sham-burned mice (P < 0.05) (Fig. 5C).  Even after normalization by IRS-1 
level, insulin-stimulated tyrosine phosphorylation of IRS-1 was also significantly 
decreased on PBD 3 (46.9±11.7% sham burn, P < 0.01) (Fig. 5D). As expected, Akt 
levels were not altered by burn injury (Fig. 5E). Insulin-stimulated phosphorylation of 
Akt was suppressed on PBD 3 (36.6 ± 7.7% sham burn, P < 0.01) (Fig. 5E), and its 
ratio to Akt was significantly suppressed on PBD 3 (58.0±11.5% sham burn, P < 0.01) 
(Fig. 5G). The time-dependent alteration of these insulin signals in skeletal muscle 
paralled tissue-specific insulin sensitivity assessed byHIC. 
DISCUSSION 
 Mice with 30% TBSA full-thickness burn developed whole-body insulin resistance 
on PBD 3, resulting from impaired insulin-stimulated glucose disappearance from 
skeletal muscle as determined by a combination study of HIC and microPET, and 
biochemical analysis of isolated skeletal muscle.  Specifically, there was inhibition of 
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IRS-1/Akt mediated insulin signaling in parallel with the HIC results.  This is the first 
report to characterize tissue-specific insulin sensitivity in vivo under insulin clamp 
conditions following burn injury in a mouse model in association with its molecular 
alterations.  
 Initially, we characterized the physiological impact of burn injury in a mouse model 
and as expected, we found that burn injury induced profound hypermetabolism and 
catabolism, which were consistent with the clinical course of burn patients with the 
exception of significant hypoglycemia and hypoinsulinemia following 15-h fasting.  In 
contrast, models using larger animals such as rabbits and rats developed hyperglycemia 
similar to that seen with burned patients even after 12-16h of fasting(31, 33), Sugita et 
al. also reported severe hypoglycemia and hypoinsulinemia after 5-h fasting in a 12% 
TBSA burned mouse model (26). The fasting blood glucose is primarily determined by 
the rate of fasting HGP(7), and therefore, these unexpected events in a mouse burn 
model could be explained by an additive effect of the long fasting time, lack of 
increased HGP in fasting conditions, and/or extremely high energy expenditure.  
Energy expenditure is approximately 4 times higher than that of a rat model of 30% 
TBSA burn injury(32).  
 Consequently, HOMA-IR, which is a widely accepted index for diabetes derived 
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from fasting blood glucose and plasma insulin concentrations, led to misinterpretation 
of whole-body insulin sensitivity in this burn mouse model on PBD 3 and 7. This 
critical finding suggests that use of the surrogate indexes to estimate whole-body insulin 
sensitivity under fasting conditions may not be useful for burned mouse models. In the 
present study, we also conducted indirect measurements including GTT and ITT to 
evaluate whole-body glucose metabolism in the burned animal model up to PBD 7 
because previous burn studies(18, 28) had demonstrated significant insulin resistance or 
glucose intolerance of burned mice on PBD 3.  Interestingly, the burned mice did not 
develop significant glucose intolerance by GTT, which is the most widely used method 
for evaluating whole-body glucose tolerance in rodent research. A possible explanation 
for this finding is that the peak plasma insulin concentration during GTT was less than 
half of that evaluated by HIC in the current study, and the level may have not reached a 
concentration high enough to produce differences in insulin-stimulated Rd between 
burned and sham-burned mice. Ferrannini et al. also reported that 30-40% of glucose is 
taken up by the splanchnic bed during GTT, and HGP is less completely suppressed 
than during the insulin clamp technique(8). As expected, ITT demonstrated that burn 
injury results in significant whole-body insulin resistance on PBD 3, which resolves by 
PBD 7. This drastic time course is consistent with the rapid recovery times of gene 
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expression (within 4 days), which is the time when the gene changes return back to half 
after reaching a maximum in a 25% TBSA burn injury mouse model as demonstrated by 
Seok J at al.(27). These results obtained from the indirect measurements suggest that 
GTT may not be useful for assessing glucose tolerance in a 30% TBSA burned mouse 
model.  
 Next, we conducted parallel HIC and microPET measurements to validate the 
results of ITT and characterize tissue-specific insulin sensitivity under insulin clamp 
conditions.  HIC showed significant whole-body insulin resistance on PBD 3 in burned 
mice, which resolved by PBD 7 and was consistent with the ITT results.  In addition, 
HICrevealed that insulin-stimulated peripheral Rd in tissues such as skeletal muscle 
and/or adipose tissue plays a role in developing the burn-induced insulin resistance.  
MicroPET following HIC demonstrated that distant skeletal muscle is responsible for 
impaired insulin-stimulated glucose uptake both visually and quantitatively. Skeletal 
muscle is responsible for 70 to 80% of whole-body insulin-stimulated glucose uptake 
under the hyperinsulinemic condition(29) and thus, impaired glucose uptake in skeletal 
muscle could contribute significantly to whole body insulin resistance in our burned 
mouse model.  In contrast, Xu et al. demonstrated that insulin resistance occurs 
predominantly in the liver and not in skeletal muscle in a 30% TBSA burned rabbit 
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model(31). In addition, intensive insulin therapy or treatment with metformin have been 
reported to suppress HGP and increase the peripheral Rd of burned patients(5, 9, 11). 
Furthermore, ex vivo studies with burned rodent models have been shown to suppress 
insulin-stimulated augmentation of 2-deoxyglucose uptake in isolated skeletal 
muscle(23, 24, 28). The discrepancy of tissue-specific insulin sensitivity among 
different species emphasizes the need to characterize tissue-specific insulin sensitivity 
carefully depending on species; otherwise, the results that are obtained may lead to 
misinterpretation. 
 Finally, we investigated the molecular alteration in skeletal muscle, which is the 
tissue responsible for burn-induced insulin resistance in our mouse model. As expected, 
in gastrocnemius muscle, impaired IRS-1/ Akt mediated insulin signal transduction, 
which is related to the time course of reduced insulin sensitivity in vivo obtained with 
HIC. Most of the previous molecular investigations of insulin signal transduction were 
conducted after various doses of insulin challenge in which the plasma insulin 
concentration and blood glucose level of the animal models were not clearly 
documented. Cree et al. successfully demonstrated that peroxisome 
proliferator-activated receptor gamma treatment could improve skeletal muscle insulin 
sensitivity in children with burns involving greater than 40% TBSA at 3 weeks 
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post-burn using insulin clamp techniques(5). This was also associated with 
improvement in insulin-stimulated IRS-1 expression in skeletal muscle.  We believe 
that it is important to investigate the molecular basis of burn-induced insulin resistance 
and the effects of novel treatments with consideration of insulin and glucose state. Our 
burned mouse model could provide a more accurate molecular and genetic basis of 
possible treatments including insulin intensive therapy(9)(30), beta-blockade(12), 
farnesyltransferase inhibitor(23), and mitochondria-targeted antioxidant peptides(18).    
 
CONCLUSIONS 
 This study clearly demonstrated that impaired glucose utilization in skeletal muscle, 
not elevated hepatic glucose production, plays a pivital role in the development of 
burn-induced insulin resistance in a mouse model. This burned mouse model could 
contribute to further explorations of the molecular and genetic alteration associated with 
burn-induced insulin resistance and may set the stage for developing more targeted 
approaches to treat altered glucose metabolism in burned patients.  
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FIGURE LEGENDS 
Figure 1. Burn-induced hypermetabolism and catabolism in a mouce model 
Dynamic change in body weight (A), organ weight of gastrocnemius muscle, 
epididymal adipose tissue and liver (B), 24-h energy expenditure (C-E), oxygen 
consumption (VO2) (F), and resting carbon dioxide production (VCO2) (G) on 
post-burn day (PBD) 1, PBD 3, and PBD 7 in burn and sham-burn pair-fed (SBP) mice 
at various time points (n=5-8 mice per group).  Data are expressed as mean ± SEM. *P 
< 0.05; **P < 0.01 vs SBP.  
 
Figure 2. Systemic insulin resistance emerged on post-burn day 3 by indirect 
measurements  
Blood glucose level (A-C) and plasma insulin concentration (D-F) during 
intraperitoneal glucose tolerance test (2 g/kg BW) on post-burn day (PBD) 1, 3, and 7 in 
burn and sham-burn pair-fed (SBP) mice (n=8 mice per group). Intraperitoneal insulin 
tolerance test (1 U/kg BW) on PBD 1, 3, and 7 (n=8 per group) (G-I). Data are 
expressed as mean ± SEM. *P < 0.05 vs SBP. 
 
Figure 3. Burned mice decreased insulin-stimulated glucose utilization in the 
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peripheral tissues by hyperinsulinemic isoglycemic clamp   
Hyperinsulinemic isoglycemic clamp results for blood glucose concentration(A-C), 
glucose infusion rate (GIR) (D-F), correlation between GIR and index of insulin 
sensitivity (SIclamp) (G), Hepatic glucose production (HGP) (H), rate of glucose 
disappearance (Rd) (I), , plasma insulin concentration (J) in burn and sham-burn 
pair-fed (SBP) mice at post-burn day (PBD) 1,3, and 7 (n=5-7 mice per group). Data are 
expressed as mean ± SEM. *P < 0.05 and **P < 0.01 vs SBP.  
Figure 4. Burned mice decreased insulin-stimulated glucose utilization in the 
skeletal muscle by hyperinsulinemic isoglycemic clamp and microPET 
Typical images of whole body microPET at basal and clamp period (insulin infusion 
rate of 2.5 mU/kg/min) in burn and sham burn pair-fed (SBP) mice at post-burn day 3 
(n=4 mice per group) (A). White arrow indicates the quadriceps. Standardized uptake 
value (SUV) in quadriceps (B). Data are expressed as mean ± SEM. *P < 0.05; #P < 
0.01 vs SBP clamp.  
Figure 5. Burn injury inhibited IRS-1 and Akt mediated insulin signaling in the 
skeletal muscle by immunoblotting 
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Typical images of immunoblotting (A), IRS-1(B), tyrosine phosphorylated IRS-1 (C), 
and insulin-stimulated phosphorylation IRS-1 ratio normalized to IRS-1 (D), Akt (E), 
serine phosphorylated Akt (F), and insulin-stimulated phospholiration Akt normalized to 
Akt in burn and sham burn pair-fed (SBP) mice on post burn day (PDB) 1, 3, and 7 (G). 
Data are expressed as mean ± SEM. *P < 0.05 and **P < 0.01 vs SBP.  
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Table 1. Dynamic change of blood glucose and plasma insulin concentration after burn 
injury 
Post-burn day  1 3 7 
Blood glucose concentration 
(mg/dl) 
Sham burn 77.7 ± 4.4 87.3 ± 5.3 81.5 ± 6.6 
Burn 67.7 ± 6.0 68.5 ± 4.1** 67.3 ± 6.5* 
Plasma insulin concentration 
(µU/ml)  
Sham burn 8.8 ± 0.7 9.0 ± 1.2 10.2 ± 1.8 
Burn 8.1 ± 1.1 5.6 ± 0.7** 5.8 ± 1.0** 
HOMA-IR 
Sham burn 1.8 ± 0.2 2.0 ± 0.4 2.1 ± 0.4 
Burn 1.2 ± 0.4 1.0 ± 0.1** 0.9 ± 0.2** 
Blood sampling was conducted in burn and sham burn mice after 15 h fasting. Homeostatic 
model assessment of insulin resistance (HOMA-IR) was calculated according to the formula: 
fasting blood glucose (mg/dl) × fasting plasma insulin concentration (µU/ml) × 405-1. 
Data are expresed as mean ± SEM. *P < 0.05; **P < 0.01 vs Sham burn. n=5-8 per each 
group. 
© 2020 Authors PREPRINT
